HCES2A-IN-2
HCES2A-IN-2 (compound 14n) is an orally active, highly specific, irreversible, covalent inhibitor of hCES2A with an IC50 of 0.04 nM. It targets and covalently binds to the catalytic serine residue (Ser-228) of hCES2A. hCES2A-IN-2 can significantly mitigate irinotecan-induced gastrointestinal toxicity (ITGT) without diminishing the antitumor efficacy of irinotecan in tumor-bearing mice.
Product Specifications
Field of Research
Metabolism Research
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15231091 1 Vial
Lentiviral mouse Hnrnpl shRNA (UAS) - Lentiviral mouse Hnrnpl shRNA (UAS) plasmid
Sign In for Pricing
View Details 
ARP57186_P050-Biotin 100 µL
Wdr41 Antibody - middle region : Biotin (ARP57186_P050-Biotin)
Sign In for Pricing
View Details 
293297-01 250 mg
Ethyl 2,3,4,6-tetra-O- (4-methoxybenzyl) -b-D-thiogalactopyranoside S-oxide
Sign In for Pricing
View Details 293297-02 500 mg
Ethyl 2,3,4,6-tetra-O- (4-methoxybenzyl) -b-D-thiogalactopyranoside S-oxide
Sign In for Pricing
View Details 293297-03 1 g
Ethyl 2,3,4,6-tetra-O- (4-methoxybenzyl) -b-D-thiogalactopyranoside S-oxide
Sign In for Pricing
View Details